The relationship between serum pentraxin 3 and central obesity in ST-segment elevation myocardial infarction patients

Korean Circulation Journal

Volumn 40, Issue 7, 2010, Pages 308-313

  Shim, Byung Ju ^a   Jeon, Hui Kyung ^a   Lee, Seung Jae ^a   Kim, Sung Sik ^a   Park, Mi Youn ^a   Lee, Dong Hyeun ^a   Shin, Woo Seung ^a   Lee, Jong Min ^a   Youn, Ho Joong ^a   Chung, Wook Sung ^a   Seung, Ki Bae ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Central obesity; Myocardial infarction; Pentraxin 3

Indexed keywords

PENTRAXIN 3;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN FUNCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 77955502197     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2010.40.7.308     Document Type: Article

References (23)

1. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
2. Noh HJ, Kwon NH, Joo SB. Severity of coronary atherosclerosis: influence of metabolic syndrome risk factor clustering and hs-CRP. Korean Circ J 2006;36:802-8.
3. Rattazi M, Faggin E, Bertipaglia B, Pauletto P. Innate immunity and atherogenesis. Lupus 2005;14:747-51.
4. Hansson GK, Robertson AL, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006;1:297-329.
5. Koo BK, Choi DH, Ryu SK, et al. Role of inflammation on coronary artery disease in Koreans. Korean Circ J 2002;32:988-95.
6. Kim TI, Chae SC, Yang DH, Shin SC, et al. Short-term prognostic value of CRP in the patients with acute coronary syndrome. Korean Circ J 2000;30:1387-94.
7. Mantovani A, Garlanda C, Bottazzi B. Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine 2003;21(Suppl 2):S43-7.
8. Mantovani A, Garlanda C, Bottazzi B, et al. The long pentraxin PTX3 in vascular pathology. Vascul Pharmacol 2006;45:326-30.
9. Napoleone E, Di Santo A, Bastone A, et al. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol 2002;22:782-7.
10. Peri G, Introna M, Corradi D, et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000;102:636-41.
11. Suzuki S, Takeishi Y, Niizeki T, et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J 2008;155:75-81.
12. Moon DK, Lee DH, Youn HJ, et al. Pentraxin 3 as an inflammatory marker in subjects with metabolic syndrome. Korean J Med 2007;451S. Abstract.
13. Alberti L, Guardini L, Zulian A, et al. Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Atherosclerosis 2009;202:455-60.
14. Kim JA, Choi CJ, Yum KS. Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population. J Korean Med Sci 2006;21:1048-53.
15. Zenetti M, Bosutti A, Ferreira C, et al. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. Clin Exp Med 2009;9:243-8.
16. Latini R, Maggioni AP, Peri G, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004;110:2349-54.
17. Introna M, Alles VV, Castellano M, et al. Cloning of mouse PTX3, a new marker of the pentraxin gene family expressed at extrahepatic sites. Blood 1996;87:1862-72.
18. Presta M, Camozzi M, Salvatori G, Rusnati M. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007;11:723-38.
19. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-83.
20. Takeno M, Yasuda S, Otsuka Y, et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction-potential association with C-reactive protein. Circ J 2008;72:415-9.
21. Clavijo LC, Pinto TL, Kuchulakanti PK, et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Rrevasc Med 2006;7:7-11.
22. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-9.
23. Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women. Circulation 2004;109:706-13.